Align Technology shares fell 1.7% in pre-market trading after Evercore ISI downgraded the stock to In Line from Outperform. The downgrade by the investment research firm signals a shift from a positive to neutral outlook on the medical device maker, which manufactures clear aligners and other orthodontic products. The move reflects analyst reassessment of the company's near-term performance prospects.
Quwwaa is your AI news butler — a personalized brief and assistant for the stories you care about.
See more on Quwwaa — create a free account